← Back to all trials
Active Not Recruiting
NCT06851507
A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses
Conditions: Multiple Actinic Keratoses
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE3
Enrollment: 18
Sponsor: M.D. Anderson Cancer Center
Location: The University of Texas M. D. Anderson Cancer Center Houston Texas
Summary
The goal of this clinical research study is to compare the effects of topical fluorouracil alone to topical fluorouracil plus topical calcipotriene in patients with multiple actinic keratoses. "Topical" means the medication is applied directly to the skin.
Eligibility Criteria
Inclusion Criteria:
* Ability to start treatment within 1 week of enrollment
* Patients must be age ≥18, not of childbearing potential, and have the presence of 4-15 clinically, visibly confirmed and discrete AKs in an at least 25 cm2 contiguous area on the head, neck, arm, or hand.
Because no dosing or adverse event data are currently available on the use of fluorouracil in combination with calcipotriene in patients \
Source: ClinicalTrials.gov (NCT06851507). StuddyBuddy aggregates publicly available trial information.
